Recital 39, Regulation (EU) 2026/2348

In force

The applications for the renewal of the approvals of the active substance for Trichoderma harzianum strains T-22 and ITEM 908 were submitted on 29 and 28 April 2016, respectively, and the rapporteur Member State informed the co-rapporteur Member State, the Commission and the Authority on 27 May 2016 that it had assessed the admissibility of the applications pursuant to Article 3 of Implementing Regulation (EU) No 844/2012, and in particular their completeness and timeliness, and concluded that they were admissible. The applications have been made public by the Authority. On 31 March 2021, the rapporteur Member State submitted the draft renewal assessment reports to the Authority, which conducted a public consultation on them between 20 July and 19 September 2021 for strain T-22, and between 13 July and 11 September 2021 for strain ITEM 908. On 13 June 2022, the Authority requested additional information for the purposes of the renewal assessment pursuant to Article 13(3) of Implementing Regulation (EU) No 844/2012 and the applicants submitted that information on 11 July 2022 within the deadline given. On 3 September 2026, the Authority adopted its conclusion for Trichoderma harzianum strain T-22 and communicated it to the applicant, the Member States and the Commission. As additional time is necessary for the Standing Committee to deliver its opinion and for the Commission to adopt the ensuing risk management decisions, the duration of the extension of the approval period should be set at 14 months, until 31 January 2028.

  • celex=32012R0844